Developing engineered biologics to harness the immune system for disease treatment.
About
Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.
Tags
Total Employees
38
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cue Biopharma, . do?
Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.
How much funding has Cue Biopharma, . raised?
Cue Biopharma, . has raised a total of $100M in funding. The most recent round on record is Series B.
Where is Cue Biopharma, . headquartered?
Cue Biopharma, . is headquartered in Boston, United States.
When was Cue Biopharma, . founded?
Cue Biopharma, . was founded in 2017.
What industry does Cue Biopharma, . operate in?
Cue Biopharma, . operates in Biotech, Drug Discovery, Immunotherapy, Therapeutics, Biologics, Immune System.
How many employees does Cue Biopharma, . have?
Cue Biopharma, . has approximately 38 people on record.